$AMZE Balance Sheet | Understand Stock

$AMZE

$0.07 +$0.00 (0.0%) Close

$AMZE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022
Assets
Current assets
Cash
Restricted cash
Accounts receivable, net
Accounts receivable - related parties, current
Due from employees – net of credit loss allowance of $0 and $20,000, respectively
Insurance recovery receivable
Other receivable
Receivables with recourse
Related party receivables
Due from employees
Prepaid expenses (long-term)
Equity investment
Note receivable, net of allowance
Inventories, net
Prepaid expenses and other
Deferred offering costs
Interest receivable
Total current assets
Related party receivables, noncurrent

Prepaid expenses (long term)
Equity investment
Total other assets
Computer equipment, net
Other assets
Fixed assets, net
Intangible assets, net
Right of use asset
Goodwill
Total other assets
Total assets
Liabilities and stockholders’ equity
Current liabilities
Accounts payable
Payroll tax payable
Accrued compensation
Accrued creator commissions
Settlement payable
Accrued expenses
Secured borrowings
Accrued expenses - related parties
Related Party
Total accrued expenses - related parties
Accrued sales tax
Deferred revenue
Note payable
Financing arrangement, net of discount
Convertible notes payable, net of discount
Notes payable, current portion, net of discount
Related party payables
Operating lease, current portion
Total current liabilities

Long-term liabilities
Operating lease, net of current portion
Total liabilities
Commitments and contingencies – Note 16
Stockholders’ equity
Preferred stock, value
Series A Preferred Stock
Series B Preferred Stock
Series C Preferred Stock
Total preferred stock, value
Series B preferred stock, $0.001 par value – 50,000 shares authorized at September 30, 2025 and December 31, 2024; 5,250 and 50,000 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively, preference in liquidation of $787,500 and $7,500,000 at September 30, 2025 and December 31, 2024, respectively
Series C preferred stock, $0.001 par value – 100,000 and 0 shares authorized at September 30, 2025 and December 31, 2024, respectively; 8,550 and 0 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively; preference in liquidation of $855,000 and $0 at September 30, 2025 and December 31, 2024, respectively
Series D preferred stock, $0.001 par value – 750,000 and 0 shares authorized at September 30, 2025 and December 31, 2024; 0 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively; preference in liquidation of $0 at September 30, 2025 and December 31, 2024
Common stock, $0.001 par value – 93,750,000 shares authorized at June 30, 2026 and December 31, 2025; 10,319,946 and 3,933,863 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity

Comments